Skip to main content
. Author manuscript; available in PMC: 2015 Feb 28.
Published in final edited form as: Toxicology. 2013 Dec 26;316:14–24. doi: 10.1016/j.tox.2013.12.001

Table 4.

Genes significantly altered by 0.5 μM Cr(VI) at passage 25 and after Cr(VI) removal for 5 passages

Cr(VI) for 25 Passages vs Control at 25 passages
symbol name Fold Change
Gm347 predicted gene 347 0.12
Sftpb surfactant associated protein B 0.14
Gm4303 predicted gene 4303 0.16
Gm4305 predicted gene 4305 0.16
Gm4307 predicted gene 4307 0.16
Mbnl3 muscleblind-like 3 (Drosophila) 0.17
Sh3rf2 SH3 domain containing ring finger 2 0.18
Phactr1 phosphatase and actin regulator 1 0.21
Fras1 Fraser syndrome 1 homolog (human) 0.23
Fcgr4 Fc receptor, IgG, low affinity IV 0.25
Speer4b spermatogenesis associated glutamate (E)-rich protein 4b 0.26
Krt8 keratin 8 1.80
Lars 2 leucyl-tRNA synthetase, mitochondrial 2.03
Fkbp8 FK506 binding protein 8 2.06
H2afj H2A histone family, member J 2.37
Capg capping protein (actin filament), gelsolin-like 2.52
Nrtn neurturin 3.25
Krt5 keratin 5 4.39
Dgkh diacylglycerol kinase, eta 4.54
Ppm1n protein phosphatase, Mg2+/Mn2+ dependent, 1N
(putative)
4.75
Tex101 testis expressed gene 101 5.08
Krt6a keratin 6A 5.29
Kcnf1 potassium voltage-gated channel, subfamily F, member 1 5.66
Alpk2 alpha-kinase 2 6.45
Col16a1 collagen, type XVI, alpha 1 9.04
Cr(VI) removed after 20 passages vs Control at passage 25
Fgf9 fibroblast growth factor 9 0.16
5430437J10Rik RIKEN cDNA 5430437J10 gene 0.11